PHARMA 4.0 SMART MANUFACTURING FORUM 2019
Vision for an Efficient, Robust, and Flexible Integrated Capability from Scale-Up to Commercial Product
November 21, 2019
New Jersey Hospital Association Conference and Event Center
Princeton, NJ
Join us at the Pharma 4.0 Smart Manufacturing Conference in Princeton, part of the ongoing Bioprocess Scale-up Series of events. Pharma and biotech development pipelines now include biologics, cell-based therapies, and vaccines (e.g., combination immune-modulatory small molecules with checkpoint antibodies) in their respective portfolios. Developing these therapeutics means facing stiff competition as many pharma companies see an opportunity in the global marketplace. Transitioning to Pharma 4.0 offers solutions to this challenge but the transition introduces challenges of its own. Bringing Pharma 4.0 online requires rolling out new technology platforms as part of a broader, coordinated business strategy. Technology leaders need a remit to be flexible enough to allow innovation, while maintaining the discipline for rigorous validation and compliance. To that end, the Pharma 4.0 Smart Manufacturing Conference is a gathering of technology leaders from pharma, biotech, and pharma suppliers who will present case studies on their experience introducing, implementing, and managing emerging technology capabilities.
Key Topics to be Covered
- Pharma 4.0: Smart Manufacturing of the Future
- Pharma 4.0 is about making the transformation to connect people and machines to improve interaction and communication
- Long-Term Goal: Better management of drug production, supply chain management, and costs of novel precision medicines for patients
- Main Topics:
- Single-Use Systems
- Continuous Processing
- Cell Culture Technology
- Emerging Technologies
Target Audience
- Those working in technologies to scale up bioprocesses for biologics, vaccines, related species for Clinical t=Trials or Scale-up to Commercialization
- Those developing and using applications to leverage bioprocessing technologies
- Vice Presidents, Executive/Senior Directors, Senior Scientists in related fields, including Licensing and Regulatory
- Laboratory and Technology Directors
- Project Managers (technical, logistical, and transitioning projects to partners)
- Technology Leaders and Researchers (processes, platforms, informatics)
- Researchers in assays, diagnostics (basic, development, validation, execution)
CALL FOR ABSTRACTS
Development and Scale-up Technologies for Manufacturing Processes for biologics, vaccines, and cell-based therapies
- Single-use Bioprocessing
- Ongoing developments and implementation for bioprocessing
- System operation and optimization
- Continuous Bioprocessing
- Analytical and process instruments to monitor batch and continuous processing
- System operation and optimization
- In-line to off-line assays and sensors to analyze and optimize processing
- Model-based controls for large-scale systems
- Sensors, monitoring, and feedback – what has worked, what needs to be developed
- Cell culture Technologies and Processes
- Processing for cell-based therapies
- Intensified high-cell density perfusion
- Cell selection technologies to increase throughput
- Harvesting, Purification, and Filtration technologies
- Quality metrics to improve product yield and purity
- Emerging Technologies for Pharma 4.0: Digital Manufacturing and Networked systems
- End-to-end Blockchain, Supply Chain management
- Artificial intelligence applied to process control technologies
- Cloud and Multi/Mobile Edge Computing IT systems to capture and manage Big Data
- IIOT – connectivity in the domain of Industrial Internet of things
- New probes, cell-free sampling and distribution, at line and on-line analytics
- Digital biomanufacturing in PD, tech. transfer and failure investigation and CAPA